These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9627365)

  • 1. Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease.
    Hoogerbrugge N; Zillikens MC; Jansen H; Meeter K; Deckers JW; Birkenhäger JC
    Metabolism; 1998 Jun; 47(6):675-80. PubMed ID: 9627365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.
    Heikkinen AM; Niskanen L; Ylä-Herttuala S; Luoma J; Tuppurainen MT; Komulainen M; Saarikoski S
    Maturitas; 1998 Jun; 29(2):155-61. PubMed ID: 9651905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
    Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein subclass distribution pattern and adiposity-associated dyslipidemia in postmenopausal women.
    Maki KC; Davidson MH; Cyrowski MS; Maki AC; Marx P
    J Am Coll Nutr; 2000 Feb; 19(1):23-30. PubMed ID: 10682872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Circulation; 2003 Aug; 108(7):808-13. PubMed ID: 12900341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
    El-Swefy SE; Asker ME; Ali SI; Mohammed HE
    Pharmacol Res; 2002 Mar; 45(3):167-73. PubMed ID: 11884211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones.
    Schwenke DC; Wagner JD; Adams MR
    J Lipid Res; 1999 Feb; 40(2):235-44. PubMed ID: 9925652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
    Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-menopausal hormone therapy reduces autoantibodies to oxidized apolipoprotein B100.
    Castanho VS; Gidlund M; Nakamura R; de Faria EC
    Gynecol Endocrinol; 2011 Oct; 27(10):800-6. PubMed ID: 21879795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
    Levy RI; Brensike JF; Epstein SE; Kelsey SF; Passamani ER; Richardson JM; Loh IK; Stone NJ; Aldrich RF; Battaglini JW
    Circulation; 1984 Feb; 69(2):325-37. PubMed ID: 6360415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women.
    Koivu TA; Dastidar P; Jokela H; Nikkari ST; Jaakkola O; Koivula T; Punnonen R; Lehtimäki T
    Atherosclerosis; 2001 Aug; 157(2):471-9. PubMed ID: 11472749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size.
    Tangney CC; Mosca LJ; Otvos JD; Rosenson RS
    Atherosclerosis; 2001 Apr; 155(2):425-30. PubMed ID: 11254913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women.
    Wolfe BM; Huff MW
    Metabolism; 1995 Mar; 44(3):410-7. PubMed ID: 7885290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hypercholesterolaemia in postmenopausal women.
    Davidson MH; Maki KC; Karp SK; Ingram KA
    Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.